Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
25.64
-0.51 (-1.95%)
Aug 18, 2026, 11:36 AM EDT - Market open
Dyne Therapeutics Market Cap
Dyne Therapeutics has a market cap or net worth of $4.79 billion as of August 18, 2026. Its market cap has increased by 171.87% in one year.
Market Cap
4.79B
Enterprise Value
4.12B
1-Year Change
171.87%
Ranking
Category
Stock Price
$25.64
ChartMarket Cap Chart
Since the IPO on September 17, 2020, Dyne Therapeutics's market cap has increased from $790.90M to $4.79B, an increase of 505.41%. That is a compound annual growth rate of 35.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 4.79B | 48.67% |
| Dec 31, 2025 | 3.22B | 34.33% |
| Dec 31, 2024 | 2.40B | 193.72% |
| Dec 29, 2023 | 816.30M | 35.12% |
| Dec 30, 2022 | 604.12M | -0.31% |
| Dec 31, 2021 | 606.03M | -36.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Definium Therapeutics | 5.73B |
| CRISPR Therapeutics AG | 5.18B |
| ACADIA Pharmaceuticals | 4.87B |
| Edgewise Therapeutics | 4.80B |
| Parabilis Medicines | 4.72B |
| Veradermics | 4.71B |
| Celcuity | 4.50B |
| Relay Therapeutics | 4.35B |